HCPLive Network

Patient-Doctor Communication Affects Cardiometabolic Medication Adherence

 
FRIDAY, Jan. 4 (HealthDay News) -- Poor communication between patients and health care providers is linked to lower cardiometabolic medication adherence, according to a study published online Dec. 31 in JAMA Internal Medicine.

Neda Ratanawongsa, M.D., M.P.H., from the University of California in San Francisco, and colleagues analyzed data from 9,377 patients in the Diabetes Study of Northern California, a race-stratified, random sample of Kaiser Permanente survey respondents. In the 12 months preceding the survey, the patients received one or more oral hypoglycemic, lipid-lowering, or antihypertensive medication. Communication with their health care provider was measured with the Consumer Assessment of Healthcare Providers and Systems Survey (CAHPS) score and four items from the Trust in Physicians and Interpersonal Processes of Care instruments. Greater than a 20 percent continuous medication gap for ongoing medication therapies was used to define poor adherence.

The researchers found that 30 percent of participants had poor cardiometabolic medication refill adherence. The adjusted prevalence of poor adherence increased by 0.9 percent (P = 0.01) for each 10-point decrease in CAHPS score. Patients who gave health care providers lower ratings for involving patients in decisions, understanding patients' problems with treatment, and eliciting confidence and trust were more likely to have poor adherence, compared with patients giving higher ratings to their physicians. Hypoglycemic medications had higher associations between communication and adherence than did other medications.

"Poor communication ratings were independently associated with objectively measured inadequate cardiometabolic medication refill adherence, particularly for oral hypoglycemic medications," the authors write.
 

Abstract
Full Text (subscription or payment may be required)

 
Copyright © 2013 HealthDay. All rights reserved.
 

Further Reading
Researchers at Hong Kong University and the Wellcome Trust Sanger Institute have identified a link between the influenza A viruses’ genetic diversity and severity of the infection.
Carol Burke, MD, FACG, FASGE, talks about her phase-3 placebo-controlled trial of Celecoxib in pediatric subjects with familial adenomatous polyposis (FAP) at the 2014 ACG Annual Meeting in Philadelphia, PA.
Carol Burke, MD, FACG, FASGE, discusses pediatric familial adenomatous polyposis (FAP) and colorectal cancer at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.
The immune system is the new focus of much work on traumatic brain injury (TBI). In a challenge to the paradigm that the blood brain barrier prevents harmful leukocytes from entering the brain, a Texas team tried to neutralize the impact of these cells. Peripheral lymphocytes are activated after TBI. They may then act as potential antigen presenting cells and get into the brain, causing cells there to degenerate.
Black women undergoing in vitro fertilization are only about half as likely as white women to become pregnant, and the racial disparity persists even when donor eggs are used. These findings are being presented at the annual meeting of the American Society for Reproductive Medicine, held from Oct. 18 to 22 in Honolulu.
Hospital conversion to for-profit status is associated with improvements in financial margins, but has no effect on process quality metrics or mortality rates, according to a study published in the Oct. 22/29 issue of the Journal of the American Medical Association
Drinking sugar-sweetened sodas may affect cellular aging by shortening telomere length, according to research published online Oct. 16 in the American Journal of Public Health.
More Reading